Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04403581
Other study ID # Egyptian doctors in COVID-19
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2020
Est. completion date June 2020

Study information

Verified date May 2020
Source Ain Shams University
Contact Riham H Raafat, MD
Phone 01000948672
Email drriham80@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Doctors are at high risk of corona virus infection (COVID-19) during pandemic. The investigators are aiming to explore the emotions, perceived stressors, knowledge and coping strategies of doctors who are working during COVID-19 pandemic in different specialties and in different hospitals by a self assessment questionnaire that was designed and modified from two previously published articles (mentioned in the references), including 7 sections with 88 questions.


Description:

Background

Corona virus disease 2019 (COVID-19), an infectious respiratory disease caused by a newly discovered corona virus in December 2019, has been recognized as a serious threat to global health. Since the WHO declared COVID-19 a pandemic in early March 2020, the WHO and the Center for Disease Control and Prevention (CDC) have been considered the most reliable sources of information for the COVID-19 global pandemic. The CDC listed moderate to severe asthma, especially if not well controlled, as high-risk for severe illness from COVID-19.

A large number of cases occurred among health care workers (HCW), which were contracted within the health care facilities. Some of the HCWs even died from the COVID-19 disease. Moreover, it was reported that unrecognized, asymptomatic patients transferred to their family or close contacts. All these factors were alarming and potentially distressing for the hospital staff who worked during the pandemic.

The severe acute respiratory syndrome (SARS) epidemic in 2003 also involved disease transmission to HCWs. Even though the fatality rates for SARS were lower than for COVID-19 infection, nonetheless, they were a cause of significant stress, emotional turmoil, and concern for all the SARS healthcare providers.

The emotions, perceived stressors, complete knowledge assessment and coping strategies of HCWs especially doctors during COVID-19 have not been explored. These issues were the intended focus of the study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 384
Est. completion date June 2020
Est. primary completion date June 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 23 Years to 55 Years
Eligibility Inclusion Criteria:

- doctors from different specialties

Exclusion Criteria:

- doctors who stopped working in the pandemic

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaire
Questionnaire for assessing stresses, knowledge and attitudes of doctors in COVID-19 pandemic

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Ain Shams University

Outcome

Type Measure Description Time frame Safety issue
Primary Cross-sectional descriptive study: Egyptian Doctors Stresses, Knowledge and Attitude during COVID-19 Pandemic Highlighting the emotional aspects, perceived stressors, level of knowledge and coping strategies of doctors who are working during COVID-19 pandemic in different hospitals by using questionnaires that the investigators gave the name "COVID-19 Doctor Stress Questionnaire" that included 7 sections with 88 questions:
Demographic data related questions
Doctors feelings related questions
Factors that help in stressing doctors
Factors help in reducing stresses
Questions detecting knowledge
Attitude towards stresses
Motives to complete work Each is answered by the participant and assessed
2 months
See also
  Status Clinical Trial Phase
Withdrawn NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Completed NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure